000 01674 a2200481 4500
005 20250517175121.0
264 0 _c20190603
008 201906s 0 0 eng d
022 _a2042-6313
024 7 _a10.2217/cer-2016-0099
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarra, Lays P
245 0 0 _aThe clinical effectiveness of insulin glargine in patients with Type I diabetes in Brazil: findings and implications.
_h[electronic resource]
260 _bJournal of comparative effectiveness research
_cSep 2017
300 _a519-527 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAdult
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aBrazil
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDiabetes Mellitus, Type 1
_xblood
650 0 4 _aFemale
650 0 4 _aGlycated Hemoglobin
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xtherapeutic use
650 0 4 _aInsulin Glargine
_xtherapeutic use
650 0 4 _aInsulin, Isophane
_xtherapeutic use
650 0 4 _aLongitudinal Studies
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aAraújo, Vânia E
700 1 _aOliveira, Gerusa Cc
700 1 _aDiniz, Leonardo M
700 1 _aGuerra Júnior, Augusto A
700 1 _aAcurcio, Francisco de Assis
700 1 _aGodman, Brian
700 1 _aÁlvares, Juliana
773 0 _tJournal of comparative effectiveness research
_gvol. 6
_gno. 6
_gp. 519-527
856 4 0 _uhttps://doi.org/10.2217/cer-2016-0099
_zAvailable from publisher's website
999 _c27613957
_d27613957